Cost-effectiveness analysis of herpes zoster vaccine in adults above 50 in Singapore

Conclusion The herpes zoster vaccination is likely to be cost-effective in societal perspective for adult over 50 years of age in Singapore.
Source: Dermatologica Sinica - Category: Dermatology Source Type: research